Viewing SEC Facts Units
Company Name:
Aclaris Therapeutics, Inc.
CIK:
1557746
Start Filing Date:
2022-07-01
End Filing Date:
2022-09-30
ACCN:
0001558370-22-016738
Value:
$ 66,675,337
Value Error:
$ None
Created By:
Date Filed:
2022-11-08
FY:
2022
Fiscal Period:
Q3
Frame:
CY2021Q3
Type:
us-gaap
Form:
10-Q
Units:
shares